Skip to main content
Clinical Trials/PER-039-00
PER-039-00Completed未知

COMPARATIVE STUDY IN PHARINGITIS AND / OR ACUTE AMIGDALITIS OF CEFALEXIN VERSUS CEFADROXILO

ELI LILLY INTERAMERICA INC.,0 sites0 target enrollmentStarted: July 17, 2000Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients from 2 years to 12 years of age.
  • Diagnosis of acute pharyngitis or acute tonsillitis (<7 days duration)
  • Rapid Strep positive test before starting treatment.
  • The parent or legal representative must sign an informed consent document approved by a CE (Ethics Committee).
  • The researcher will try to select those patients with a history of complying with the instructions received.

Exclusion Criteria

  • Patients whose symptoms are due to evident viral infection of the upper respiratory tract.
  • Researchers and their immediate family members are not allowed to be subjects or patients in studies sponsored by Lilly. As an immediate family member, the researcher´s spouse, parents, children, grandparents or grandchildren are defined.
  • Persons who have previously completed this study or withdrawn from it will not be eligible to participate in this study.
  • Reaction of severe hypersensitivity prior to cephalosporins or penicillin.
  • Administration of systemic antibiotics in the 7 days prior to randomization.
  • Inability to go to assessment consultation.
  • Concomitant use of probenecid or concomitant treatment with corticosteroids.
  • History of significant renal deterioration.
  • Any condition that, in the opinion of the investigator, could impede the evaluation of the response.
  • Patients who have received an agent in research (a drug that has not been approved for sale in the countries in which this study is conducted) as participants in a study, in the last 30 days.

Investigators

Similar Trials

COMPARATIVE STUDY IN PHARINGITIS AND / OR... | Clinical Trial